| 摘要 |
The present invention is directed to a pharmaceutical composition comprising 0.5 ng to 20 ~g desmopressin and a pharmaceutically acceptable carrier. The present invention is also directed to a pharmaceutical composition comprisin g desmopressin and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is effective to establish a steady plasma/serum desmopressin concentration in the range of from about 0.1 picograms desmopressin per mL plasma/serum to about 10.0 picogram desmopressin per mL plasma/serum. Articles of manufacture and methods of using the above inventi on are also disclosed.
|
